Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06401759
Other study ID # 2024/04-47
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2024
Est. completion date August 1, 2025

Study information

Verified date May 2024
Source Firat University
Contact Gülcan Bahçecioglu Turan
Phone 506 557 60 86
Email glcnbah@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypertension is an important public health problem all over the world due to its high prevalence and its association with increased risk of cardiovascular disease. At the same time, it is a condition in which acquired factors, genetic and metabolic disorders, characterized by increased intra-arterial blood pressure, occur together . According to the World Health Organization, hypertension is defined as systolic blood pressure of 140 mmHg and diastolic blood pressure of 90 mmHg or above According to the Arterial Hypertension Management 2018 Implementation Guide of the European Society of Cardiology and the European Society of Hypertension, it is estimated that there are more than 1 billion hypertension patients in the world and this number will reach 1.5 billion by 2025. In our country, there are approximately 20 million individuals with hypertension. It is thought to be Hypertension treatment is a lifelong process that includes lifestyle changes and patient education along with medical treatment.Turkish Endocrinology and Metabolism. The aim of hypertension treatment is to ensure that blood pressure decreases to the targeted level, to minimize target organ damage and complications caused by hypertension, to eliminate symptoms and reduce drug side effects, to ensure patient compliance with treatment and to provide self-management skills by enabling the patient to take an active role in his own treatment. The concept of self-management; It includes providing individuals with knowledge and skills regarding disease management, providing support to maintain the individual's self-care, supporting the decision-making process, and helping to recognize and cope with problems. The main goal in hypertension treatment is to control the patient's blood pressure. Achieving and maintaining self-management is also one of the most effective factors in controlling blood pressure. Inadequately treated and low self-management In hypertension patients, blood pressure control is inadequate and health risks increase. Therefore, all strategies implemented to increase self-management in hypertension patients also have positive effects on the individual's blood pressure control and disease prognosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 92
Est. completion date August 1, 2025
Est. primary completion date December 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Education level must be at least primary school level. - Patients with or without treatment experience - Being between the ages of 18 and 65 - Being diagnosed with hypertension at least 6 months ago - Being using at least one hypertensive drug - Having enough internet to listen to podcasts on Spotify - Have Spotify supported devices (iOS 14 or above, Android OS 5.0 or above, OS X 10.15 or above, Windows 10 or above) - Being competent in using a mobile phone - Having 18.64 points and above in e-health literacy assessment Exclusion Criteria: - Those who have physical (speech, hearing impairment, etc.), neurological and psychological problems that prevent them from filling out research forms and participating in training. - Those who do not have sufficient equipment (mobile phone or computer with internet connection) for podcast training - Intervention group patients who do not listen to podcasts on Spotify (patients who do not fill out verbally or Google forms (Diary)) - Patients in the control group who were understood to have logged in to their account on Spotify and listened to podcasts.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Podcast
Routine maintenance will be applied.

Locations

Country Name City State
Turkey Firat university Elazig Center

Sponsors (1)

Lead Sponsor Collaborator
Firat University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hill Bone Hypertension Treatment Compliance Scale Measures treatment compliance of hypertension patients. was developed for evaluation. The Cronbach's Alpha value of the scale was found to be between 0.74 and 0.84. The scale is a 4-point Likert type and consists of 14 items and 3 sub-dimensions. The subscales of the scale are Interview (6th, 7th and 8th Questions), Medical (1st, 2nd, 9th, 10th, 11th, 12th, 13th and 14th Questions) and Nutrition (3rd, 14th Questions). 4th and 5th Questions). Question 6 on the scale is reverse coded. The total score range on the scale varies between 0 and 42. If the person gives the most positive answers to all questions and receives a total of 0 points, he or she is considered fully compliant. Scores outside zero indicate the degree of non-compliance. Since the questions are in the negative type of questions, the compliance decreases as the score increases. Before and 12 weeks after application
Primary Self-Care Management Scale in Chronic Diseases It was developed to evaluate self-care management in chronic diseases. (The scale has a 5-point Likert structure (1=strongly disagree, 2=disagree, 3=undecided, 4=agree, 5=strongly agree) and consists of 35 items. The scale consists of two sub-dimensions. These sub-dimensions are: "self-protection" ( articles 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and "social protection" (articles 1, 3, 4, 5, 7, 9, 10, 12, 13 , 14, 16, 17, 21, 24 and 35 items. The 3rd, 15th, 19th and 28th items in the scale are negative expressions. The total scores that can be obtained from the scale vary between 35 and 175 points. It indicates that the individual's self-care management also increases Before and 12 weeks after application
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A